Literature DB >> 28489697

Validating the Quality of Life After Brain Injury Through Rasch Analysis.

Feng-Hang Chang1, Chih-Yi Chen, Wen-Miin Liang, Mau-Roung Lin.   

Abstract

OBJECTIVE: The Quality of Life after Brain Injury (QOLIBRI), a cross-cultural instrument, has been validated in several languages; however, traditional psychometric approaches have critical limitations. Therefore, we applied the Rasch model for validating the 37-item QOLIBRI scale among a Chinese population with traumatic brain injury. PARTICIPANTS AND
SETTING: In total, 587 participants (mean age: 44.2 ± 15.4 years; women, 46.3%) were surveyed in neurosurgery departments at 6 hospitals in Taipei, Taiwan. MAIN OUTCOME MEASURE: The QOLIBRI.
RESULTS: Of the 6 subscales of the QOLIBRI, 4 (cognition, self, daily life and autonomy, and social relationships) were unidimensional, valid, and reliable, whereas the remaining 2 (emotions and physical problems) exhibited poor unidimensionality, item and person reliability, and person-item targeting. Five items (energy, concentrating, getting out and about, sex life, and achievements) showed considerable differential item functioning among age groups, disability levels, and time since traumatic brain injury.
CONCLUSION: According to item response theory, we identified psychometric issues in the emotions and physical problems subscales of the QOLIBRI as well as several differential item functioning items. Future research is required to determine whether similar results are observed in other language versions of the QOLIBRI or in other countries.

Entities:  

Mesh:

Year:  2017        PMID: 28489697     DOI: 10.1097/HTR.0000000000000258

Source DB:  PubMed          Journal:  J Head Trauma Rehabil        ISSN: 0885-9701            Impact factor:   2.710


  1 in total

1.  Quality of life after traumatic brain injury: a cross-sectional analysis uncovers age- and sex-related differences over the adult life span.

Authors:  Katrin Rauen; Claudia B Späni; Maria Carmela Tartaglia; Maria Teresa Ferretti; Lara Reichelt; Philipp Probst; Barbara Schäpers; Friedemann Müller; Klaus Jahn; Nikolaus Plesnila
Journal:  Geroscience       Date:  2020-10-17       Impact factor: 7.713

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.